Laura Litwin

Laura Litwin

Articles by Laura Litwin

Laura LitwinNon-Small Cell Lung Cancer | February 27, 2025
Clinicians hypothesize that the genetic mutation, known as RUFY1-RET fusion, caused resistance to lorlatinib.
Read More
Laura LitwinLung Cancer | February 18, 2025
A multicenter study that included 21,062 patients who were seen from 2009-2021 in South Korea provided key insights.
Robert E. Merritt, MD, MBA, FACSNon-Small Cell Lung Cancer | February 7, 2025
Dr. Merritt shares new thoracic surgery research insights for patient selection in sublobar resection for early-stage NSCLC.
Laura LitwinAtrial Fibrillation | February 6, 2025
Physicians leveraged a surgical technique to achieve partial cardiac denervation, reducing the incidence of POAF post-CABG.
Laura LitwinStroke | January 30, 2025
Insights from a new AHA scientific statement outline how palliative care can improve quality of life for survivors of stroke.
Robert E. Merritt, MD, MBA, FACSNon-Small Cell Lung Cancer | January 29, 2025
Robert E. Merritt, MD, MBA, FACS, shares insights on his systematic review of sublobar resection and lobectomy.
Laura LitwinEGFR+ NSCLC | January 22, 2025
The ORR of the external control group was 3%, while it was 36.8% in those who received amivantamab for NSCLC.
Laura LitwinCardiology | January 21, 2025
Learn how wildfire smoke from western Canada in June 2023 correlated with cardiopulmonary disease burden in Maryland.
Laura LitwinNon-Small Cell Lung Cancer | January 17, 2025
Learn how sublobar resection showed "comparable oncologic outcomes and complication rates" as lobectomy per a recent review.
Laura LitwinEGFR+ NSCLC | January 8, 2025
For patients with NSCLC and EGFR mutations, amivantamab plus carboplatin-pemetrexed shows OS benefits versus chemo alone.
Laura LitwinPreventive Cardiology | January 7, 2025
According to several studies, anti-obesity medications demonstrate cardiovascular benefits beyond weight loss alone.
Laura LitwinGastric Cancer | January 8, 2025
A recent study reviewed global disparities in gastric cancer screening, finding limited research about screening feasibility.
Laura LitwinHepatocellular Carcinoma | January 6, 2025
A recent study showed evidence that HBV infection facilitates drug resistance in cancer treatment medications.
Laura LitwinNon-Small Cell Lung Cancer | December 27, 2024
Home-based exercise programs after lung cancer resection do not improve physical function in patients with NSCLC.
Laura LitwinNon-Small Cell Lung Cancer | December 26, 2024
Implementing pretreatment frailty assessments into clinical workflows may help identify patients at risk of poor outcomes.
Laura LitwinLung Cancer | December 24, 2024
A new study illustrated the importance of exercise for patients with lung cancer who experience cancer-related fatigue.
Laura LitwinLung Cancer | December 23, 2024
Researchers evaluated if commercially available AI software was capable of detecting lung cancer in chest radiographs.
Laura LitwinLung Cancer | December 16, 2024
Researchers say the conventional criteria may underestimate the condition in Asian patients with lung cancer.
Laura LitwinHypertension | December 12, 2024
Older adults diagnosed with hypertension can alleviate lung function impairments and mechanics with an active lifestyle.
Laura LitwinAtrial Fibrillation | December 12, 2024
A recent study evaluated the association between resting heart rate and incident atrial fibrillation in Black patients.